Hypocalciuric hypercalcemia, familial, type I - CISMeF
Hypocalciuric hypercalcemia, familial, type IOMIM Phenotype
Preferred Label : Hypocalciuric hypercalcemia, familial, type I;
Symbol : HHC1;
CISMeF acronym : FBH1; FHH; FHH1; HHC1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Familial benign hypercalcemia 1; Hypercalcemia, familial benign; FHH1; FBH1; Hhc; FHH;
Included titles and symbols : Hypocalciuric hypercalcemia, acquired;
Description : Familial hypocalciuric hypercalcemia (HHC) is a heritable disorder of mineral homeostasis
that is transmitted as an autosomal dominant trait with a high degree of penetrance.
HHC is characterized biochemically by lifelong elevation of serum calcium concentrations
and is associated with inappropriately low urinary calcium excretion and a normal
or mildly elevated circulating parathyroid hormone (PTH; 168450) level. Hypermagnesemia
is typically present. Individuals with HHC are usually asymptomatic and the disorder
is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults
(summary by Hannan et al., 2010). - Genetic Heterogeneity of Hypocalciuric Hypercalcemia
Familial hypocalciuric hypercalcemia type II (HHC2; 145981) is caused by mutation
in the GNA11 gene (139313) on chromosome 19p13, and HHC3 (600740) is caused by mutation
in the AP2S1 gene (602242) on chromosome 19q13.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the calcium-sensing receptor gene (CASR, 601199.0001);
Laboratory abnormalities : Hypocalciuria; Hypercalcemia; Hypermagnesemia; Urinary calcium-creatinine ratio 0.01:1 supports diagnosis; Normal concentration of parathyroid hormone; Hypercalciuria (in some patients);